These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35371663)

  • 21. Clinical Outcomes of Endoscopic Hemostasis in Marginal Ulcer Bleeding.
    Yamasaki Y; Takenaka R; Hori K; Takemoto K; Kawano S; Kawahara Y; Fujiki S; Okada H
    Acta Med Okayama; 2016 Dec; 70(6):469-475. PubMed ID: 28003672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perils and pitfalls of long-term effects of proton pump inhibitors.
    Wilhelm SM; Rjater RG; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Outcome of Upper Gastrointestinal Bleeding Post-coronary Artery Bypass Graft.
    Aljarallah B; Wong W; Modry D; Fedorak R
    Int J Health Sci (Qassim); 2008 Jan; 2(1):69-76. PubMed ID: 21475474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
    Rababa M; Rababa'h A
    BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pantoprazole.
    Poole P
    Am J Health Syst Pharm; 2001 Jun; 58(11):999-1008. PubMed ID: 11402494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.
    Barkun AN; Bardou M; Kuipers EJ; Sung J; Hunt RH; Martel M; Sinclair P;
    Ann Intern Med; 2010 Jan; 152(2):101-13. PubMed ID: 20083829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.
    Khuroo MS; Khuroo MS; Farahat KL; Kagevi IE
    J Gastroenterol Hepatol; 2005 Jan; 20(1):11-25. PubMed ID: 15610441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pantoprazole-induced thrombocytopenia.
    Watson TD; Stark JE; Vesta KS
    Ann Pharmacother; 2006 Apr; 40(4):758-61. PubMed ID: 16569810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
    Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia.
    Wauters L; Ceulemans M; Frings D; Lambaerts M; Accarie A; Toth J; Mols R; Augustijns P; De Hertogh G; Van Oudenhove L; Tack J; Vanuytsel T
    Gastroenterology; 2021 Apr; 160(5):1521-1531.e9. PubMed ID: 33346007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM; Prakash A; Faulds D; Lamb HM
    Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?
    Kim KR; Jun CH; Cho KM; Wi JW; Park SY; Cho SB; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    Korean J Intern Med; 2015 Sep; 30(5):593-601. PubMed ID: 26354053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS; Berardi RR
    J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro.
    Escoffier J; Arnaud B; Kaba M; Hograindleur JP; Le Blévec E; Martinez G; Stévant I; Ray PF; Arnoult C; Nef S
    Andrology; 2020 Nov; 8(6):1795-1804. PubMed ID: 32609951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
    Laria A; Zoli A; Gremese E; Ferraccioli GF
    Reumatismo; 2011 Mar; 63(1):5-10. PubMed ID: 21509344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitor administration delays rebleeding after endoscopic gastric variceal obturation.
    Jang WS; Shin HP; Lee JI; Joo KR; Cha JM; Jeon JW; Lim JU
    World J Gastroenterol; 2014 Dec; 20(45):17127-31. PubMed ID: 25493026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
    Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
    J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.